Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze GH Guardant Health, Inc.. Please read: https://finlab.finance/en/setup?stock=GH

No install, open FinLab Studio

GH

Guardant Health, Inc. Healthcare As of 2026-07-31 Updated daily after market close

quality needs a look, discounted valuation.

2 active signals
Top-quintile 6-month momentum Filed revenue acceleration
This page refreshes daily after the close. Add Guardant Health, Inc. to your watchlist to track signal changes on your next visit.
Valuation 77Quality 45Growth 71Momentum 98Risk / liquidity 65

Is Guardant Health, Inc. a buy? Fundamentals and valuation first

  • Quality is weaker than peers. Operating margin is only around the 17th percentile. TTM ROE is about 239.2%.

  • Valuation is cheaper than most peers. TTM P/E is in the 6th percentile, lower than most liquid US common stocks.

  • Recent volatility is moderate. 60-day annualized volatility is near the 65th percentile. Average 20-day dollar volume is about $344.2M.

  • Signals are active now. Top-quintile 6-month momentum, Filed revenue acceleration currently holds; the tables below show what followed in this stock’s own history.

Historical evidence

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 89.70212765957447%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

26 historical occurrences (since 2019-04-08)
Average forward return after Top-quintile 6-month momentum。20-day: Win 60%, Sample 25, Median +4.05%, Excess +4.06%, Beat mkt rate 64%；60-day: Win 62.5%, Sample 24, Median +13.91%, Excess +8%, Beat mkt rate 45.8%；120-day: Win 54.5%, Sample 22, Median +4.5%, Excess -0.2%, Beat mkt rate 40.9%

120 days after: historical avg +10.99%

20-day +5.38%
60-day +13.85%
120-day +10.99%
20-day
60-day
120-day
Win
60%
62.5%
54.5%
Sample
25
24
22
Median
+4.05%
+13.91%
+4.5%
Excess
+4.06%
+8%
-0.2%
Beat mkt rate
64%
45.8%
40.9%

Over 22 occurrences, 120-day forward avg gained 10.99%, lagged the market by 0.2 pts; win rate 54.5%.

Filed revenue acceleration

Active · now 39.56338275650004%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

17 historical occurrences (since 2019-05-10)
Average forward return after Filed revenue acceleration。20-day: Win 52.9%, Sample 17, Median +9.96%, Excess +6.01%, Beat mkt rate 58.8%；60-day: Win 50%, Sample 16, Median +0.59%, Excess +4.66%, Beat mkt rate 50%；120-day: Win 53.3%, Sample 15, Median +5.59%, Excess +10.47%, Beat mkt rate 60%

120 days after: historical avg +13.05%

20-day +6.82%
60-day +6.7%
120-day +13.05%
20-day
60-day
120-day
Win
52.9%
50%
53.3%
Sample
17
16
15
Median
+9.96%
+0.59%
+5.59%
Excess
+6.01%
+4.66%
+10.47%
Beat mkt rate
58.8%
50%
60%

Over 15 occurrences, 120-day forward avg gained 13.05%, beat the market by 10.47 pts; win rate 53.3%.

Market-wide momentum baseline

Across 97,878 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.26%, a 58.3% positive-return rate, and +2.90 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

12 times historically; 60-day forward avg +25.22%, win rate 90%, beating the market by +22.5 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

17 times historically; 60-day forward avg +10.84%, win rate 52.9%, beating the market by +7.73 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.